New technology for identifying respiratory viruses
Official title: ResVir Novel Technologies for Respiratory Virus Identification
Run by Portsmouth Hospitals NHS Trust · NCT05661032 · Data updated 2026-11-12
This study is testing a new technology that quickly identifies different respiratory viruses from throat swabs to see if it can help doctors manage infections better.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Portsmouth Hospitals NHS Trust Government |
| Locations | 1 site (Portsmouth, Hampshire) |
| Status | Recruiting |
| Started | January 18, 2023 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT05661032 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with clinical suspicion of a respiratory viral infection who can provide nasopharyngeal swab specimens.
✕Probably not a fit
Patients who are unable to provide nasopharyngeal swabs or those lacking the capacity to consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of the Pictura Bio system, a novel rapid pathogen identification technology, in detecting and differentiating respiratory viruses from nasopharyngeal swabs. The study will collect data to train algorithms that enhance the accuracy of virus identification. By monitoring the system's performance over time, researchers hope to improve its sensitivity and specificity for clinical use. The ultimate goal is to provide a rapid, cost-effective diagnostic tool that can help manage respiratory infections more effectively.
Why it matters
Potential benefit: If successful, this technology could lead to faster and more accurate diagnoses of respiratory infections, reducing unnecessary antibiotic use and improving patient outcomes.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving rapid virus detection methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provide informed, (parental/guardian, where appropriate) consent * Able to provide nasopharyngeal swab/aspirate specimens. * A clinical suspicion of a respiratory viral infection with one or more of the following symptoms: * Coryzal symptoms (runny nose, sneezing and/or nasal congestion) * New onset of cough * Sore throat * Head and/or Muscle aches * Fever or chills Exclusion Criteria: * Unable to comply with study procedures or where in the opinion of the investigator, undertaking a nasopharyngeal swab may be detrimental to the individual * Lacking capacity to consent
Where it's running
-
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, United Kingdom Recruiting
Study contacts
- Principal investigator: Sharon Glaysher, Dr — Portsmouth University Hospital NHS Trust
- Study coordinator: Yvette Hibberd
- Email: Yvette.hibberd@porthosp.nhs.uk
- Phone: 023 9228 6000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Baloxavir for preventing flu after exposure in household contacts
A single dose of baloxavir marboxil is being tested to see if it prevents symptomatic, lab-confirmed influenza in people who live with someone who has flu symptoms.
-
Stop antibiotics early when symptoms stop in kids after IV treatment
This trial tests whether stopping oral antibiotics as soon as symptoms disappear is just as effective as finishing the prescribed course for kids who had IV antibiotics for cellulitis, UTI, LRTI, or lymphadenitis.
-
Testing single and multiple IV doses of JKN2501 in healthy Chinese adults
This test gives single and multiple intravenous doses of JKN2501 to healthy Chinese adults to see if it's safe and how the body processes it.
-
Families' views on antibiotic length and using a smartwatch to track children's symptoms
We will see if families are comfortable with shorter antibiotic courses and if a Garmin smartwatch can help track symptoms in children aged 4–17 with uncomplicated infections.
-
Comparing intravenous and oral antibiotics for acute infections
This study tests if oral antibiotics can work just as well as intravenous ones for people in the hospital with acute infections to see if they can shorten hospital stays and lower risks.
-
Vitamin D supplementation during pregnancy to prevent early childhood asthma
This study is testing if giving high-dose vitamin D to pregnant women can help prevent asthma and wheezing in their children by the time they reach three years old.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.